Company Overview and News

 
Tata-backed Indian Hotels to feel the heat of foreign rivals on home turf

2018-04-04 moneycontrol
At a time when hotel companies in India are busy gearing up for a surge in room occupancy rates like never before the Tata Group-backed Indian Hotels Company (IHCL) may be faced with challenges. Yet another restructuring exercise at the company could mean limited supply of new properties.

 
Two state-owned hotels to be leased out soon: DIPAM Secy

2018-02-05 moneycontrol
Two state-owned ITDC hotels will soon go for auction as part of government's plans to privatise these properties, a senior government official said today.

 
Railways will run on ‘care’ track: Lohani

2018-01-19 thehindubusinessline
Brand Indian Railways, the single largest national transporter that moves the largest number of people globally every year, intends to stand for ‘We care’, says Ashwani Lohani, who took over as the Chairman five months back.

 
Budget 2018: Fiscal balance – Modi government will look at the market to rescue it again in FY19

2018-01-11 moneycontrol
With less than three weeks for the Union Budget, speculation about the fine print has begun. The fiscal math suggests that the government may not be able to adhere to the FRBM (fiscal responsibility and budget management) targets for FY19. That is because the government will have to be mindful of electoral politics ahead of the 2019 elections even as it tries to revive the economy. And while the fiscal picture may not be as bleak so as to invite the ire of the rating agencies, the government will need an extremely supportive capital markets in FY19 to keep things under control.

 
ITDC net loss widens to Rs 8.35 cr in Q2

2017-11-16 thehindubusinessline
India Tourism Development Corporation (ITDC) has reported a ₹8.35 crore net loss in the second quarter of financial year 2017-2018. This is more than double the ₹3.01 crore loss reported by the public sector undertaking in the corresponding quarter of the last financial year.

 
ITDC presents Rs 9.93-cr dividend cheque to Tourism Minister

2017-11-01 thehindubusinessline
The Chairperson and Managing Director, India Tourism Development Corporation (ITDC), Ravneet Kaur, on Wednesday presented a cheque of Rs 9.93 cr to Tourism Minister K J Alphons for the financial year 2016-17, on behalf of ITDC. The amount was paid by the ITDC to the government, which is the largest shareholder of the company. Government of India has 87.03 per cent of the paid-up capital of the company.

 
Centre to exit 3 ITDC hotels, handover stakes to state govts

2017-09-20 livemint
New Delhi: As part of the disinvestment exercise, the Centre on Wednesday decided to exit three India Tourism Development Corp (ITDC) hotels and handover them to the state governments.

 
Major bureaucratic reshuffle: 35 secretaries, additional secretaries in govt depts

2017-07-22 freepressjournal.in
New Delhi: Thirty-five IAS officers have been appointed as secretaries and additional secretaries in various central government departments as part of a major bureaucratic reshuffle.

 
India Tourism Development Corporation sees room for growth outside hotels

2017-06-08 business-standard
As a premium subscriber you get an across device unfettered access to a range of services which include:

 
Centre to pull out from three Ashoka Hotels

2017-05-04 freepressjournal.in
NEW DELHI : The Union Cabinet on Wednesday decided to pull out India Tourism Development Corporation (ITDC) from three Ashoka Hotels it were running in Bhopal, Bharatpur and Guwahati as part of the disinvestment policy.

 
Cabinet approves govt’s exit from three ITDC hotels

2017-05-03 thehindubusinessline
The Union Cabinet on Wednesday approved a proposal for the Centre to exit three Ashoka hotels of the India Tourism Development Corporation (ITDC) Ltd in Bharatpur, Bhopal and Guwahati.

 
ITDC to exit Ashok hotels in Bhopal, amnd Bharatpur

2017-05-03 livemint
The decision by ITDC to exit Hotel Lake View Ashok, Hotel Brahmaputra Ashok and Hotel Bharatpur Ashok was taken at the meeting of CCEA

 
Market Live: Sensex breaks 30000 in opening, Nifty falls further on weak Asian cues

2017-04-28 moneycontrol
10:25 am FII view: Michael Hartnett of Bank of America Merrill Lynch says 2017 total returns for both stocks and bonds have been impressive in the face of Donald Trump disappointment, European Union politics, peak PMI narrative.

 
ITDC up 10%, sign MoUs to transfer stake in JV to State govts

2017-04-28 moneycontrol
Shares of India Tourism Development Corporation (ITDC) rose 10 percent intraday Friday as the company has entered into MoU with state governments to transfer its stake in the joint ventire subsidiary companies.

 
ITDC seeks shareholders’ nod for divesting stake in hotels

2017-04-14 livemint
ITDC is looking to divest or offload its stake in all hotels run by it except Ashok and Samrat hotels in Delhi

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

23h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...